SAMBUCUS CANADENSIS (Rxhomeo Private Limited d.b.a. Rxhomeo, Inc)


Welcome to the PulseAid listing for the SAMBUCUS CANADENSIS drug offered from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
NON-PROPRIETARY NAME: SAMBUCUS CANADENSIS
SUBSTANCE NAME: SAMBUCUS CANADENSIS FLOWERING TOP
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-09-05
END MARKETING DATE: 0000-00-00


SAMBUCUS CANADENSIS HUMAN OTC DRUG Details:

Item DescriptionSAMBUCUS CANADENSIS from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
LABELER NAME: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 1([hp_X]/1)
START MARKETING DATE: 2015-09-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 15631-0387_19eecf62-64ac-43f7-bca4-8314719179a7
PRODUCT NDC: 15631-0387
APPLICATION NUMBER:

Other SAMBUCUS CANADENSIS FLOWERING TOP Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Rxhomeo Private Limited d.b.a. Rxhomeo, IncSAMBUCUS CANADENSIS